Metformine Hydrochloride Inventia

Metformin Hydrochloride, the active ingredient in Metformine Hydrochloride Inventia, is a biguanide presented as an oral tablet for oral use. It is employed to lower elevated blood glucose levels in adults with type 2 diabetes mellitus. The medication works by decreasing hepatic glucose output and improving peripheral insulin sensitivity, helping patients achieve better glycemic control.

GNH USA supplies Metformine Hydrochloride Inventia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is an oral antidiabetic agent used in the management of disorders related to glucose metabolism.

- Type 2 diabetes mellitus: improves glycemic control by reducing fasting and post‑prandial blood glucose levels.

Metformine Hydrochloride Inventia may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Diarrhea: frequent loose stools, often transient. - Abdominal discomfort: cramping or bloating. - Metallic taste: temporary alteration of taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycemia: when combined with insulin or secretagogues. - Acute renal failure: especially in dehydrated patients. - Anemia: due to chronic B12 deficiency.

When prescribing Metformine Hydrochloride Inventia, clinicians should consider several safety measures to minimize risk.

- Renal function assessment: evaluate eGFR before initiation and periodically thereafter. - Lactic acidosis risk: avoid in patients with severe renal or hepatic impairment. - Alcohol consumption: limit intake to reduce lactic acidosis potential. - Pregnancy and breastfeeding: discuss risks and benefits with the healthcare provider. - Drug interactions: review concomitant medications for possible interactions. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metformin Hydrochloride can affect, or be affected by, various concomitant medicines.

Major Interactions (Avoid): - Iodinated contrast media: may precipitate acute renal failure. - Cimetidine: can increase metformin plasma concentrations. - Nitrates: combined use may raise risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Thiazide diuretics: can attenuate glucose‑lowering effect. - ACE inhibitors or ARBs: monitor renal function and electrolytes.